BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27358233)

  • 1. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
    Dias da Silva D; Silva MJ; Moreira P; Martins MJ; Valente MJ; Carvalho F; Bastos ML; Carmo H
    Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models.
    Dias-da-Silva D; Arbo MD; Valente MJ; Bastos ML; Carmo H
    Toxicol In Vitro; 2015 Aug; 29(5):987-96. PubMed ID: 25863214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment.
    Arbo MD; Silva R; Barbosa DJ; da Silva DD; Rossato LG; Bastos Mde L; Carmo H
    Toxicol Lett; 2014 Aug; 229(1):178-89. PubMed ID: 24968061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination effects of amphetamines under hyperthermia - the role played by oxidative stress.
    da Silva DD; Silva E; Carmo H
    J Appl Toxicol; 2014 Jun; 34(6):637-50. PubMed ID: 23765447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
    Schep LJ; Slaughter RJ; Vale JA; Beasley DM; Gee P
    Clin Toxicol (Phila); 2011 Mar; 49(3):131-41. PubMed ID: 21495881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol addictively enhances the in vitro cardiotoxicity of cocaine through oxidative damage, energetic deregulation, and apoptosis.
    Martins MJ; Roque Bravo R; Enea M; Carmo H; Carvalho F; Bastos ML; Dinis-Oliveira RJ; Dias da Silva D
    Arch Toxicol; 2018 Jul; 92(7):2311-2325. PubMed ID: 29846769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
    Wood DM; Button J; Lidder S; Ramsey J; Holt DW; Dargan PI
    J Med Toxicol; 2008 Dec; 4(4):254-7. PubMed ID: 19031377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
    Fantegrossi WE; Winger G; Woods JH; Woolverton WL; Coop A
    Drug Alcohol Depend; 2005 Feb; 77(2):161-8. PubMed ID: 15664717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): emergence of two agents which lead to misuse].
    Lecompte Y; Roussel O; Perrin M
    Ann Pharm Fr; 2008 Mar; 66(2):85-91. PubMed ID: 18570904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic effects and their action mechanism of the major active components of party pill drugs.
    Min CR; Kim MJ; Park YJ; Kim HR; Lee SY; Chung KH; Oh SM
    Toxicol Lett; 2012 Nov; 214(3):339-47. PubMed ID: 23026265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.
    Lee H; Wang GY; Curley LE; Sollers JJ; Kydd RR; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2016 Mar; 233(5):863-71. PubMed ID: 26630992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL; Katz EB; Coop A; Fantegrossi WE
    Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neurotoxic effects of 3-TFMPP derivatives.
    Majrashi M; Almaghrabi M; Fadan M; Fujihashi A; Lee W; Deruiter J; Randall Clark C; Dhanasekaran M
    Life Sci; 2018 Sep; 209():357-369. PubMed ID: 30067941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.
    Elliott S; Smith C
    J Anal Toxicol; 2008 Mar; 32(2):172-7. PubMed ID: 18334102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
    Lee H; Wang GY; Curley LE; Kydd RR; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2869-77. PubMed ID: 27289365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo interactions between BZP and TFMPP (party pill drugs).
    Antia U; Tingle MD; Russell BR
    N Z Med J; 2009 Sep; 122(1303):29-38. PubMed ID: 19851418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
    Vorce SP; Holler JM; Levine B; Past MR
    J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.